Method For Predicting Biological Systems Responses

• US 20090170091A1
• Filed: 01/17/2007
• Published: 07/02/2009
• Est. Priority Date: 01/17/2006
• Status: Abandoned Application

• Current Assignee: Cellumen, Inc.
• Original Assignee: Cellumen, Inc.
• Inventors: Johnston, Patricia A., Giuliano, Kenneth, Taylor, D. Lansing, Gough, Albert H.
• Application Number:
  US12/087,809
• Publication Number:
  US 20090170091A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: G01N 33/5008 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Abstract

The inventive method employs a “systems biology” approach to predicting biological responses resulting from exposure to the test substance. In one embodiment, the invention provides an automated method for predicting the biological systems effects of a test substance. In another embodiment, the invention provides a method for constructing a knowledgebase (or database) of response profiles for reference substances with known biological systems effects. In another embodiment, the invention provides a set of protocols and software tools used to carry out the profiling. Another embodiment of the invention is a panel of reagents and protocols required for generating response profiles, either to create an knowledgebase, or to use with an existing knowledgebase and informatics software to profile substance physiological effects. Another embodiment of the invention is a database of physiological profiles.

Claims

1. A method for predicting the biological systems effects of a test substance comprising:

a) providing a battery of cells to be treated;

b) incubating the cells with the test substance;

c) acquiring images of cells within the battery;

d) analyzing the images to measure or detect cellular features indicative of cellular functional classes;

e) creating a response profile comprising at least 6 of the cellular features; and

f) comparing the response profile of the test substance to a database of response profiles for substances with known biological systems effects;

wherein the extent of correlation between the response profile of the test substance to the database of response profiles for substances with known biological systems effects indicates the probability that the test substance will exhibit a biological systems effect in a living cell, tissue or organism.

3. The method of claim 1 wherein, prior to acquiring the images, the cells contain one or more fluorescent or luminescent reporters.

4. The method of claim 3, wherein the cells express one or more fluorescent or luminescent reporters.

5. The method of claim 3, wherein one or more one or more fluorescent or luminescent reporters is introduced into the cells.

6. The method of claim 1, wherein the images of cells are obtained after labeling with one or more fluorescent or luminescent reporters targeting cellular features indicative of cellular functional classes.

7. The method of claim 3, wherein a reporter molecule is selected from the group consisting of fluorescent labels, fluorescent proteins, luminescent labels, and biosensors.

8. The method of claim 1, wherein, prior to acquiring the images, the cells contain one or more manipulation.

9. The method of claim 8, wherein a manipulation is selected from the group consisting of expression of a protein, knock-down of the expression of a protein, addition of a stimulus of known response or addition of a substance which induces differentiation of stem cells.

10. The method of claim 1, wherein, the cells are fixed prior to acquiring images of the cells.

11. The method of claim 1, wherein the cells are imaged live.

12. The method of claim 1, wherein images are analyzed using an algorithm to extract information from the images to produce outputs of the cellular features.

13. The method of claim 1, where the features are combined into a response profile using a method comprising cluster analysis.

14. The method of claim 1, wherein the cells are contacted with an array of substance concentrations and a response profile is constructed for each concentration.

15. The method of claim 1, wherein the battery of cells to be treated comprises 2 or more cell types.

16. The method of claim 1, wherein the scanning of the cells is repeated multiple times and analysis is performed at each time point to capture a kinetic response.

17. The method of claim 1, wherein the cellular features are selected from 2 or more functional response classes in the group consisting of cell proliferation, stress pathways, organelle function, cell cycle state, morphology, apoptosis, DNA damage, metabolism, signal transduction, cell differentiation and cell-cell interaction.

18. The method of claim 17 wherein the cellular features indicating cell proliferation are selected from the group consisting of nuclear count, cell count, total cell mass, total DNA, the phosphorylation state of cell cycle regulatory proteins, and the post-translational modification state of any protein involved in cell growth or division.

19. The method of claim 17 wherein the cellular features indicating stress pathway activation are selected from the group consisting of transcription factor activation of NF-κ

B, AP1, ATF2, MSK1, CREB, or NFAT, and kinase activation of p38, JNK, ERK, RSK90 or MEK.

20. The method of claim 17 wherein the cellular features indicating organelle function are selected from the group consisting of cytoskeletal organization, mitochondrial mass or membrane potential, peroxisome mass, golgi organization, and plasma membrane permeability.

21. The method of claim 17 wherein the cellular features indicating cell cycle state are selected from the group consisting of DNA content, Histone H3 phosphorylation state, Rb phosporylation state, cyclin B1 (CDKI) biosynthesis, cyclin DI (CDK4, 6) biosynthesis, and cyclin E (CDK2) biosynthesis.

22. The method of claim 17 wherein the cellular features indicating morphology are selected from the group consisting of motility, cell spreading, adhesion, ruffling, neurite outgrowth and colony formation.

23. The method of claim 17 wherein the cellular features indicating apoptosis are selected from the group consisting of nuclear size and shape, DNA content and degradation, caspase activation, phosphatidyl-expression, and Bax translocation.

24. The method of claim 17 wherein the cellular features indicating DNA damage are selected from the group consisting of repair protein (APE) expression, tumor suppressor (p53, Rb) expression, oxidative activity (8-oxoguanine), and transcription activity (Oct1).

25. The method of claim 17 wherein the cellular features indicating metabolism are selected from the group consisting of cAMP concentration, P-glycoprotein activity or CYP450 induction/inhibition, and the concentration of an added substance.

26. The method of claim 17 wherein the cellular features indicating signal transduction are selected from the group consisting of Ca++ ion concentration, (pH) expression of a protein, activation of a protein, modification of a protein, translocation of a protein, and interaction between proteins known to be associated with a specific pathway.

27. The method of claim 17 wherein the cellular features indicating cell differentiation are selected from the group consisting of expression of a tissue specific protein and exhibiting a tissue specific morphology.

28. The method of claim 17 wherein the cellular features indicating cell-cell interactions are selected from the group consisting of concentration of tight junction proteins at a cell-cell interface, and transfer of material from one cell to another.

29. The method of claim 1, wherein the cellular features are selected from 2 or more functional response classes in the group consisting of cell proliferation, cell cycle, apoptosis, oxidative stress, stress kinase activation, mitochondrial function, DNA damage, and peroxisome proliferation.

30. The method of claim 29, wherein one of the cellular features is cell loss.

31. The method of claim 29, wherein one of the cellular features is DNA degradation.

32. The method of claim 29, wherein one of the cellular features is cell cycle arrest.

33. The method of claim 29, wherein one of the cellular features is nuclear size.

34. The method of claim 29, wherein one of the cellular features is histone H2A.X phosphorylation level.

35. The method of claim 29, wherein one of the cellular features is c-jun phosphorylation level.

36. The method of claim 29, wherein one of the cellular features is p53 activation.

37. The method of claim 29, wherein one of the cellular features is mitochondrial membrane potential.

38. The method of claim 29, wherein one of the cellular features is mitochondrial mass.

39. The method of claim 29, wherein one of the cellular features is histone H3 phosphorylation.

40. The method of claim 29, wherein one of the cellular features is microtubule stability.

41. The method of claim 1, wherein profiles are built from the feature measurements comprising:

a) calculating a parameter such as Kolmogorov-Smirnov values or average values as a measure of cell population shifts for each feature measurement at each compound concentration for each compound to generate parameters for dilution series,

b) fitting such dilution series parameters using a 4-parameter logistic fit;

c) analyzing the resulting fitted data to calculate EC50 values;

d) converting the EC50 values to log scale as a measure of compound activity; and

e) using cluster analysis to identify similarities in profiles as well as correlations between cellular systems responses.

2. A method for constructing a database of response profiles for reference substances with known biological systems effects comprising:

a) providing a battery of cells to be treated;

b) incubating the cells with the a first reference substance;

c) acquiring images of cells within the battery;

d) analyzing the images to measure or detect cellular features indicative of cellular functional classes;

e) creating a response profile comprising at least 6 of the cellular features;

f) adding the response profile for the first reference substance to the database; and

g) optionally repeating steps a-f substituting a second reference substance for the first reference substance.

48. A database constructed in accordance with the method of claim 2.

42. A kit comprising one or more reagents and instructions for employing the reagents to assay a battery of cells in accordance with a protocol involving

a) incubating a battery of cells with a test or reference substance;

b) acquiring images of cells within the battery;

c) analyzing the images to measure or detect cellular features

d) indicative of cellular functional classes; and

e) creating a response profile comprising at least 6 of the cellular features.

43. The kit of claim 42, further comprising instructions for comparing the response profile of a test substance to a database of response profiles for substances with known biological systems effects.

44. The kit of claim 42, further comprising instructions for adding the response profile of a reference substance to a database of response profiles for substances with known biological systems effects.

45. The kit of claim 42, further comprising a database of response profiles for substances with known biological systems effects.

46. The kit of claim 42, wherein one or more reagents comprise a fluorescent or luminescent label.

47. The kit of claim 42, wherein one or more reagents comprise a culture of cells.